- BMI alone can miss health risks in nearly 50% of adults due to its inability to capture critical nuances of metabolic health.
- A study of over 40,000 adults found that nearly half of those with obesity-related cardiometabolic abnormalities had a normal BMI.
- About 30% of individuals with high BMI were actually metabolically healthy, highlighting the metric’s limitations.
- Visceral fat accumulation, often overlooked by BMI, is a significant predictor of health risks.
- The widespread reliance on BMI for obesity assessment may lead to undiagnosed and untreated health issues in millions of adults.
In a quiet exam room in suburban Chicago, Maria Gonzalez, 42, was told she was ‘within a healthy weight range’ based on her body mass index (BMI). Her blood pressure was normal, she didn’t smoke, and her doctor gave her a clean bill of health. But three months later, she was diagnosed with type 2 diabetes and elevated triglycerides. “I thought I was doing everything right,” she said. “But my waist size had crept up to 38 inches, and no one ever measured it.” Maria’s experience is not unique. Across the United States, millions of adults are being misclassified by a decades-old metric that healthcare providers rely on to assess obesity-related risk—BMI—despite mounting evidence that it fails to capture critical nuances of metabolic health.
Half of At-Risk Adults Overlooked by BMI
A landmark 2016 study published in International Journal of Obesity analyzed data from over 40,000 adults and found that nearly half of those with obesity-related cardiometabolic abnormalities—including insulin resistance, high triglycerides, and low HDL cholesterol—were classified as ‘metabolically unhealthy’ despite having a normal BMI. Conversely, about 30% of individuals with high BMI were metabolically healthy. The study revealed that relying solely on BMI could misclassify up to 74 million U.S. adults, leaving those with dangerous visceral fat accumulation undiagnosed and untreated. Waist circumference, a more direct measure of abdominal fat, was shown to be a far stronger predictor of cardiovascular disease and diabetes risk. Yet, fewer than 15% of primary care visits include routine waist measurements, according to the CDC.
How We Got Here: The Legacy of BMI
BMI was developed in the 1830s by Belgian mathematician Adolphe Quetelet as a population-level statistic, never intended for individual health assessment. It gained traction in the U.S. in the 1970s when researchers sought a simple, scalable way to categorize weight in large studies. By the 1990s, the World Health Organization and the National Institutes of Health adopted BMI thresholds to define overweight and obesity, cementing its role in clinical practice. But the formula—weight in kilograms divided by height in meters squared—does not distinguish between muscle and fat, nor does it account for fat distribution. A bodybuilder and a sedentary person can have the same BMI, despite vastly different health profiles. Similarly, Asian populations often develop metabolic disease at lower BMIs, while Black and Hispanic individuals may carry weight differently, making BMI thresholds less accurate across racial and ethnic groups.
The Doctors and Researchers Pushing for Change
Dr. Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women’s Hospital, has long advocated for a more nuanced approach. “We need to treat obesity as a disease defined by health risk, not just a number on a scale,” she said in a 2022 interview with The Associated Press. She and other experts, including those at the American Medical Association, now recommend assessing ‘adiposity-based chronic disease,’ which considers waist circumference, blood biomarkers, liver function, and inflammation markers. Endocrinologist Dr. Ken Fujioka has led efforts to integrate body composition scans into clinical trials, arguing that tools like DEXA and MRI, though costly, reveal fat deposits around organs that BMI completely misses. Their push reflects a broader shift toward precision medicine in obesity care.
Consequences for Patients and the Healthcare System
When patients like Maria are misclassified, they often miss early interventions such as lifestyle counseling, diabetes screening, or referrals to nutritionists. Insurance companies frequently tie coverage for weight-loss treatments to BMI thresholds, denying care to those below 30 despite clear metabolic dysfunction. This not only delays treatment but reinforces stigma, as individuals with high BMIs are often blamed for poor health regardless of their actual biomarkers. For the healthcare system, the cost is staggering: undiagnosed metabolic syndrome contributes to higher rates of heart attacks, strokes, and hospitalizations. A 2023 study in Health Affairs estimated that improving early detection could save $19 billion annually in preventable care.
The Bigger Picture
Reimagining how we assess obesity is about more than medical accuracy—it’s about equity and dignity. Relying on a flawed, one-size-fits-all metric perpetuates disparities, particularly among women and people of color who are more likely to carry visceral fat at lower BMIs. As science advances, so must clinical practice. Countries like the U.K. and Japan have already begun integrating waist-to-height ratios into national screening programs. The U.S. lags behind, but momentum is growing. The National Heart, Lung, and Blood Institute is currently revising its obesity guidelines, with recommendations expected in 2025.
What comes next may be a fundamental shift in how medicine defines health. Rather than relying on a single number from the 19th century, clinicians could adopt a holistic profile combining body composition, metabolic markers, and patient history. For millions, that could mean earlier diagnoses, personalized care, and a chance to avoid preventable disease. The tools exist. The science supports it. Now, the challenge is implementation.
Source: Earth